Showing results (41-50 of 70) with videos related to
Sort By:
Pageof 7
Cancers|June 2, 2021
Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma PatientsSarah Zhou, Daniel Sikorski, Honghao Xu, et al.The American Journal of Surgical Pathology|January 15, 2026
Pathologic Assessment of Retroperitoneal Sarcomas: A Position Paper By the Transatlantic Australasian Retroperitoneal Sarcoma Working GroupBibianna Purgina, Elena Di Blasi, Paola Collini, et al.Cell Death & Disease|July 28, 2018
Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cellsAndrew Sulaiman, Sarah McGarry, Ka Mien Lam, et al.Annals of Surgical Oncology|June 8, 2022
Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma: An International Multi-institutional CollaborationRichard J B Walker, Nicole J Look Hong, Marc Moncrieff, et al.Journal of Cancer Research and Clinical Oncology|February 8, 2021
Personalized oncology and BRAFK601N melanoma: model development, drug discovery, and clinical correlationBrian A Keller, Brian J Laight, Oliver Varette, et al.Annals of Surgical Oncology|July 14, 2025
Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Eyal Mor, Sameer Apte, Catherine Mitchell, et al.Annals of Surgical Oncology|May 13, 2022
Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter StudyMarc D Moncrieff, Serigne N Lo, Richard A Scolyer, et al.Annals of Surgical Oncology|May 15, 2025
Radiologic and Pathologic Response Evaluation After Neoadjuvant Chemotherapy for Primary Retroperitoneal Sarcoma: A Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) CollaborationStijn J C van der Burg, Marco Fiore, Piotr Rutkowski, et al.Journal of the National Cancer Institute|June 15, 2026
Utility of recurrence-based surrogate endpoints for survival in adjuvant cancer trials: evidence from melanomaSophie E Orme, Serigne N Lo, Robyn P Saw, et al.Annals of Surgical Oncology|February 27, 2025
Examining the Impact of Biopsy Technique on Clinical and Pathologic Outcomes in Dermatofibrosarcoma Protuberans: An International, Multi-Institutional StudyLeah K Winer, Jordan D Fredette, Jill Hasler, et al.Pageof 7